March 18, 2024 |
We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option. Yet, some people are holding onto the idea of in-person meetings being superior. In this article, we’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put this idea to rest.
I’ve written and talked about the blindspots of in-person meetings for over 16 years now, but it’s only been in the past few years that the benefits of virtual engagements have gained mainstream acceptance. There are multiple reasons why in-person-only meetings should be laid to rest, including, but not limited to, the facts that they are:
Specifically for advisory boards and other insight-gathering initiatives, the in-person-only approach comes with additional pain points such as:
Most important, though, is the fact that participants don’t want only in-person meetings. Based on our survey of hundreds of healthcare provider advisors in 2022–2023, over three-quarters stated that they prefer virtual/hybrid meetings, with the convenience and flexibility of digital meetings rated as the top benefits…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Christine Jacob, Founder and Managing Director of Digi-Bridges, talks about the future of mobile and digital health, including exciting technologies such as VR and AR. We also touch on a wide variety…
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual “hackathon,” with spectacular results.
Leo Grady, CEO of Paige.AI uncovers what it has been like being a pioneer in the digital therapeutic space and the many challenges that come with bringing AI technology to market….
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented…
In this episode of Impetus Digital’s Fireside Chat, I sit down with Brenda McPhail from the Canadian Civil Liberties Association. We talk about a myriad of different subjects related to…
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)…
In this fireside chat, Natalie Yeadon sat down with Jeffrey Ruby, Founder & CEO of Newtopia and discussed how a combination of genetic testing, personality-matched coaching, and smart technology can…
We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions.
In this Fireside Chat, Natalie Yeadon sat down with Anand Iyer, Chief Strategy Officer at Welldoc and discussed a myriad of different topics, including AI and MR in healthcare and…
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with an all-star panel of industry leaders who are also members of TECHNATION Health. I had the pleasure…
